Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer’s disease neuropathological deficits

Shah, S A, Yoon, G H, Chung, S S, Abid, M N, Kim, T H, Lee, H Y, Kim, M O·2017·Molecular Psychiatry
DOI 10.1038/mp.2016.23

Cited by (206)

Items 201–206 of 206

  1. Isoform-specific roles and overlooked complexity of AMPKα in Alzheimer's disease
    Helena R. Zimmermann, Hannah M. Jester, Robert J. Vassar, Tao Ma · 2026 · Brain medicine :
  2. Integrative SMR prioritizes oxidative stress–related regulatory genes for Alzheimer’s disease with brain-tissue validation
    Liu Wu, Yuting Dong, Xin Mu, Xiao Luo, Zejun Chen · 2026 · The Journal of Prevention of Alzheimer s Disease
  3. METTL16 Promotes Head and Neck Squamous Cell Carcinoma Progression via m6A ‐Mediated Stabilization of SREBP2 mRNA and Enhanced Cholesterol Biosynthesis
    Xinrui Ma, Xiaojun Ding, Jianhua Deng, Qian Gao, Huiting Liu, Shuo Yuan, Zhi Xiao, Rui Jiang · 2026 · Cancer Medicine
  4. The protective effects of dexmedetomidine via AMPK/SIRT1 pathway activation in a rat model of alzheimer’s disease: evidence from preliminary findings
    Mina Mohasel‐Roodi, Masoumeh‎‏‏ Nozari, Masoumeh Baghalishahi, Ali Shamsara · 2026 · Molecular Biology Reports
  5. Neuroprotective effects of thiamine against LPS-induced neuroinflammation, synaptic dysfunction, and memory impairment in mice
    Irfan Safdar Durrani, Dawood Ahmad, Asad Jan · 2026 · World Journal of Biology and Biotechnology
  6. SIRT1 in brain aging: molecular mechanisms and therapeutic potential of pharmacological and natural modulators
    Esraa M. Mosalam, Mahmoud S. Abdallah, Ahmed R. Gardouh, Eman Hamza, Mostafa M. Bahaa, Mahmoud Nazih, Reham Abdullah Al-Dhelaan, Noha Kamal · 2026 · Biogerontology